hydroxychloroquine has been researched along with Complications, Infectious Pregnancy in 27 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the use of chloroquine (C) and hydroxychloroquine (HC) in the treatment of malaria prophylaxis during pregnancy is probably safe, the use of much higher doses for treatment of systemic lupus erythematosus (SLE) and rheumatoid arthritis during pregnancy has been controversial." | 7.68 | Pregnancy outcome following first trimester exposure to chloroquine. ( Buskila, D; Gladman, DD; Koren, G; Levy, M; Urowitz, MB, 1991) |
| "The pregnancy is still ongoing without any visible sequelae on the foetus so far." | 5.56 | COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. ( Calès, P; Delaroche, L; Descamps, P; Dieli-Crimi, R; Guerin, A; Lamazou, F; Letouzey, V; Octernaud, S; Oger, P; Place, V, 2020) |
| "Hydroxychloroquine is a treatment for rheumatic disease and considered safe during pregnancy." | 4.02 | Maternal exposure to hydroxychloroquine and birth defects. ( Ailes, EC; Broussard, CS; Browne, ML; Carmichael, SL; Fisher, SC; Heinke, D; Howley, MM; Mitchell, AA; Pruitt, SM; Reefhuis, J; Van Zutphen, AR; Werler, MM, 2021) |
| "Although the use of chloroquine (C) and hydroxychloroquine (HC) in the treatment of malaria prophylaxis during pregnancy is probably safe, the use of much higher doses for treatment of systemic lupus erythematosus (SLE) and rheumatoid arthritis during pregnancy has been controversial." | 3.68 | Pregnancy outcome following first trimester exposure to chloroquine. ( Buskila, D; Gladman, DD; Koren, G; Levy, M; Urowitz, MB, 1991) |
| " Therefore, it is important to know the utility and safety of the medications to avoid untoward adverse effects on pregnant women and fetuses." | 2.72 | Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective. ( Bhagat, R; Manchanda, K; Singh, H; Singh, J; Tiwana, IK, 2021) |
| "Pregnancy seems to increase the risk of thrombotic thrombocytopenic purpura (TTP) relapses and make the TTP more severe in any of the pregnancy trimesters, or even during the postpartum period." | 1.62 | A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report. ( Afrooz, N; Aminimoghaddam, S; Mahmoudzadeh, F; Motaghi Nejad, O; Nasiri, S, 2021) |
| "Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020." | 1.56 | Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. ( Andrikopoulou, M; Aubey, J; Baptiste, C; Bernstein, K; Breslin, N; D'Alton, ME; Friedman, AM; Fuchs, K; Goffman, D; Gyamfi-Bannerman, C; Landau, R; Martinez, R; Miller, R; Moroz, L; Mourad, M; Purisch, S; Ring, L; Rupley, D; Sheen, JJ; Simpson, LL; Sutton, D; Wapner, R; Zork, N, 2020) |
| "The worldwide incidence of coronavirus disease 2019 (COVID-19) infection is rapidly increasing, but there exists limited information on coronavirus disease 2019 in pregnancy." | 1.56 | Coronavirus disease 2019 in pregnancy: early lessons. ( Baptiste, C; Breslin, N; D'Alton, M; Fuchs, K; Goffman, D; Gyamfi-Bannerman, C; Miller, R, 2020) |
| "Hydroxychloroquine was used to treat both patients; the first patient was treated with it over a period of 14 days before showing signs of improvement." | 1.56 | Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report. ( Atef-Yekta, R; Jafary, M; Lamsehchi, A; Sadeghi, K; Sagheb, S, 2020) |
| "The pregnancy is still ongoing without any visible sequelae on the foetus so far." | 1.56 | COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. ( Calès, P; Delaroche, L; Descamps, P; Dieli-Crimi, R; Guerin, A; Lamazou, F; Letouzey, V; Octernaud, S; Oger, P; Place, V, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 23 (85.19) | 2.80 |
| Authors | Studies |
|---|---|
| Westhoff, WJ | 1 |
| Smith, LH | 1 |
| Wyszynski, DF | 1 |
| Hernandez-Diaz, S | 1 |
| Polkinghorne, A | 1 |
| Branley, JM | 1 |
| Favre, G | 3 |
| Gerbier, E | 3 |
| Maisonneuve, E | 3 |
| Pomar, L | 3 |
| Winterfeld, U | 3 |
| Lepigeon, K | 3 |
| Bloemenkamp, KWM | 3 |
| de Bruin, O | 3 |
| Hurley, E | 3 |
| Nordeng, H | 3 |
| Siiskonen, SJ | 3 |
| Sturkenboom, MCJM | 3 |
| Baud, D | 3 |
| Panchaud, A | 3 |
| Breslin, N | 2 |
| Baptiste, C | 2 |
| Gyamfi-Bannerman, C | 2 |
| Miller, R | 2 |
| Martinez, R | 1 |
| Bernstein, K | 1 |
| Ring, L | 1 |
| Landau, R | 1 |
| Purisch, S | 1 |
| Friedman, AM | 1 |
| Fuchs, K | 2 |
| Sutton, D | 1 |
| Andrikopoulou, M | 1 |
| Rupley, D | 1 |
| Sheen, JJ | 1 |
| Aubey, J | 1 |
| Zork, N | 1 |
| Moroz, L | 1 |
| Mourad, M | 1 |
| Wapner, R | 1 |
| Simpson, LL | 1 |
| D'Alton, ME | 1 |
| Goffman, D | 2 |
| LaCourse, S | 1 |
| John-Stewart, G | 1 |
| Adams Waldorf, KM | 1 |
| Juusela, A | 1 |
| Nazir, M | 1 |
| Gimovsky, M | 1 |
| D'Alton, M | 1 |
| González, R | 1 |
| García-Otero, L | 1 |
| Pons-Duran, C | 1 |
| Marbán-Castro, E | 1 |
| Goncé, A | 1 |
| Llurba, E | 1 |
| Gil, MDM | 1 |
| Rodríguez-Zambrano, MÁ | 1 |
| Chen, H | 1 |
| Ramírez, M | 1 |
| Bardají, A | 1 |
| Menendez, C | 1 |
| Oliva, M | 1 |
| Hsu, K | 1 |
| Alsamarai, S | 1 |
| Chavez, V | 1 |
| Ferrara, L | 1 |
| Faden, YA | 1 |
| Alghilan, NA | 1 |
| Alawami, SH | 1 |
| Alsulmi, ES | 1 |
| Alsum, HA | 1 |
| Katib, YA | 1 |
| Sabr, YS | 1 |
| Tahir, FH | 1 |
| Bondagji, NS | 1 |
| Sagheb, S | 1 |
| Lamsehchi, A | 1 |
| Jafary, M | 1 |
| Atef-Yekta, R | 1 |
| Sadeghi, K | 1 |
| Giampreti, A | 1 |
| Eleftheriou, G | 1 |
| Gallo, M | 1 |
| Butera, R | 1 |
| Contessa, G | 1 |
| Faraoni, L | 1 |
| Sangiovanni, A | 1 |
| Negri, G | 1 |
| Falchi, G | 1 |
| Bacis, G | 1 |
| Di Mascio, D | 1 |
| D'Antonio, F | 1 |
| Lamazou, F | 1 |
| Oger, P | 1 |
| Dieli-Crimi, R | 1 |
| Guerin, A | 1 |
| Letouzey, V | 1 |
| Octernaud, S | 1 |
| Place, V | 1 |
| Calès, P | 1 |
| Descamps, P | 1 |
| Delaroche, L | 1 |
| Khan, MSI | 1 |
| Nabeka, H | 1 |
| Akbar, SMF | 1 |
| Al Mahtab, M | 1 |
| Shimokawa, T | 1 |
| Islam, F | 1 |
| Matsuda, S | 1 |
| Manchanda, K | 1 |
| Singh, J | 1 |
| Bhagat, R | 1 |
| Tiwana, IK | 1 |
| Singh, H | 1 |
| Ortiz Molina, E | 1 |
| Hernandez Pailos, R | 1 |
| Pola Guillen, M | 1 |
| Pascual Pedreno, A | 1 |
| Rodriguez Rodriguez, E | 1 |
| Hernandez Martinez, A | 1 |
| Dima, A | 1 |
| Jurcut, C | 1 |
| Arnaud, L | 1 |
| Sisti, G | 1 |
| Schiattarella, A | 1 |
| Sisti, A | 1 |
| Aminimoghaddam, S | 1 |
| Afrooz, N | 1 |
| Nasiri, S | 1 |
| Motaghi Nejad, O | 1 |
| Mahmoudzadeh, F | 1 |
| Dubey, P | 1 |
| Thakur, B | 1 |
| Reddy, S | 1 |
| Martinez, CA | 1 |
| Nurunnabi, M | 1 |
| Manuel, SL | 1 |
| Chheda, S | 1 |
| Bracamontes, C | 1 |
| Dwivedi, AK | 1 |
| Axfors, C | 1 |
| Schmitt, AM | 1 |
| Janiaud, P | 1 |
| Van't Hooft, J | 1 |
| Abd-Elsalam, S | 1 |
| Abdo, EF | 1 |
| Abella, BS | 1 |
| Akram, J | 1 |
| Amaravadi, RK | 1 |
| Angus, DC | 1 |
| Arabi, YM | 1 |
| Azhar, S | 1 |
| Baden, LR | 1 |
| Baker, AW | 1 |
| Belkhir, L | 1 |
| Benfield, T | 1 |
| Berrevoets, MAH | 1 |
| Chen, CP | 1 |
| Chen, TC | 1 |
| Cheng, SH | 1 |
| Cheng, CY | 1 |
| Chung, WS | 1 |
| Cohen, YZ | 1 |
| Cowan, LN | 1 |
| Dalgard, O | 1 |
| de Almeida E Val, FF | 1 |
| de Lacerda, MVG | 1 |
| de Melo, GC | 1 |
| Derde, L | 1 |
| Dubee, V | 1 |
| Elfakir, A | 1 |
| Gordon, AC | 1 |
| Hernandez-Cardenas, CM | 1 |
| Hills, T | 1 |
| Hoepelman, AIM | 1 |
| Huang, YW | 1 |
| Igau, B | 1 |
| Jin, R | 1 |
| Jurado-Camacho, F | 1 |
| Khan, KS | 1 |
| Kremsner, PG | 1 |
| Kreuels, B | 1 |
| Kuo, CY | 1 |
| Le, T | 1 |
| Lin, YC | 1 |
| Lin, WP | 1 |
| Lin, TH | 1 |
| Lyngbakken, MN | 1 |
| McArthur, C | 1 |
| McVerry, BJ | 1 |
| Meza-Meneses, P | 1 |
| Monteiro, WM | 1 |
| Morpeth, SC | 1 |
| Mourad, A | 1 |
| Mulligan, MJ | 1 |
| Murthy, S | 1 |
| Naggie, S | 1 |
| Narayanasamy, S | 1 |
| Nichol, A | 1 |
| Novack, LA | 1 |
| O'Brien, SM | 1 |
| Okeke, NL | 1 |
| Perez, L | 1 |
| Perez-Padilla, R | 1 |
| Perrin, L | 1 |
| Remigio-Luna, A | 1 |
| Rivera-Martinez, NE | 1 |
| Rockhold, FW | 1 |
| Rodriguez-Llamazares, S | 1 |
| Rolfe, R | 1 |
| Rosa, R | 1 |
| Røsjø, H | 1 |
| Sampaio, VS | 1 |
| Seto, TB | 1 |
| Shahzad, M | 1 |
| Soliman, S | 1 |
| Stout, JE | 1 |
| Thirion-Romero, I | 1 |
| Troxel, AB | 1 |
| Tseng, TY | 1 |
| Turner, NA | 1 |
| Ulrich, RJ | 1 |
| Walsh, SR | 1 |
| Webb, SA | 1 |
| Weehuizen, JM | 1 |
| Velinova, M | 1 |
| Wong, HL | 1 |
| Wrenn, R | 1 |
| Zampieri, FG | 1 |
| Zhong, W | 1 |
| Moher, D | 1 |
| Goodman, SN | 1 |
| Ioannidis, JPA | 1 |
| Hemkens, LG | 1 |
| Howley, MM | 1 |
| Werler, MM | 1 |
| Fisher, SC | 1 |
| Van Zutphen, AR | 1 |
| Carmichael, SL | 1 |
| Broussard, CS | 1 |
| Heinke, D | 1 |
| Ailes, EC | 1 |
| Pruitt, SM | 1 |
| Reefhuis, J | 1 |
| Mitchell, AA | 1 |
| Browne, ML | 1 |
| Cao, B | 2 |
| Parnell, LA | 1 |
| Diamond, MS | 1 |
| Mysorekar, IU | 2 |
| Sheth, MN | 1 |
| Levy, M | 1 |
| Buskila, D | 1 |
| Gladman, DD | 1 |
| Urowitz, MB | 1 |
| Koren, G | 1 |
| Greenberg, AE | 1 |
| Kloser, P | 1 |
| Deloron, P | 1 |
| Williams, SB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single Center, Randomized, Controlled Trial of the Safety and Efficacy of Progesterone for the Treatment of COVID-19 in Hospitalized Men[NCT04365127] | Phase 1 | 40 participants (Actual) | Interventional | 2020-04-27 | Completed | ||
| Valuation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19[NCT04598347] | 225 participants (Anticipated) | Observational [Patient Registry] | 2020-08-08 | Recruiting | |||
| Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum[NCT04410562] | Phase 3 | 129 participants (Actual) | Interventional | 2020-05-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for hydroxychloroquine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Medications for early treatment of COVID-19 in Australia.
Topics: Antibodies, Monoclonal; Antibodies, Viral; Antiviral Agents; COVID-19 Drug Treatment; Female; Humans | 2022 |
Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
Topics: Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drugs, Investigational; | 2021 |
Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
Topics: Antirheumatic Agents; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Infant, Newborn; | 2021 |
Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Asia; Cesarean Section; COVID-19; COVID-19 Drug Trea | 2021 |
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Topics: Adult; Child; Chloroquine; Combined Modality Therapy; Comorbidity; COVID-19; COVID-19 Drug Treatment | 2021 |
1 trial available for hydroxychloroquine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
Topics: Antiviral Agents; Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug | 2020 |
21 other studies available for hydroxychloroquine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
COVID-19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy.
Topics: COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Infant, Newborn; Pregnancy; P | 2022 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Topics: Antiviral Agents; COVID-19; Female; Humans; Hydroxychloroquine; Inpatients; Pregnancy; Pregnancy Com | 2023 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Importance of Inclusion of Pregnant and Breastfeeding Women in COVID-19 Therapeutic Trials.
Topics: Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; COVID-19 Drug T | 2020 |
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi | 2020 |
Coronavirus disease 2019 in pregnancy: early lessons.
Topics: Acute Kidney Injury; Adult; Anesthesia, General; Anti-Bacterial Agents; Antihypertensive Agents; Azi | 2020 |
Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceft | 2020 |
Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019.
Topics: Anticoagulants; Antiviral Agents; Betacoronavirus; Congenital Abnormalities; Coronavirus Infections; | 2020 |
Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report.
Topics: Adult; Antiviral Agents; Betacoronavirus; Blood Chemical Analysis; Coronavirus Infections; COVID-19; | 2020 |
Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy.
Topics: Abnormalities, Drug-Induced; Adult; Antiviral Agents; Azithromycin; Betacoronavirus; Congenital Abno | 2020 |
Perinatal mortality and morbidity of SARS-COV-2 infection during pregnancy in European countries: Findings from an international study.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Asia; Asymptomatic Infections; Austr | 2021 |
COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report.
Topics: Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Diagnosis, Differ | 2020 |
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers.
Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Congenital Abnormalities; COVID-1 | 2020 |
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
Topics: Adult; Anosmia; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; C-Reactive Protein; Cesarea | 2020 |
Treatment of COVID-19 in Pregnancy with Hydroxychloroquine and Azithromycin: a case report.
Topics: Anti-Bacterial Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Enzyme Inhibitors; Female; H | 2020 |
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.
Topics: Acute Kidney Injury; Amphetamine-Related Disorders; Antiviral Agents; COVID-19; Drug Combinations; E | 2021 |
Maternal exposure to hydroxychloroquine and birth defects.
Topics: COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Maternal Exposure; Pregnancy; Pregnancy | 2021 |
Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice.
Topics: Animals; Autophagy; Female; Hydroxychloroquine; Infectious Disease Transmission, Vertical; Mice; Mic | 2017 |
To Zika and destroy: an antimalarial drug protects fetuses from Zika infection.
Topics: Animals; Antimalarials; Autophagy; Disease Models, Animal; Drug Repositioning; Female; Fetus; Humans | 2018 |
Pregnancy outcome following first trimester exposure to chloroquine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Arthritis, Rheumatoid; Chloro | 1991 |
Assessment of possible drug-resistant Plasmodium falciparum in a pregnant traveller with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Drug Resistance, Microbial; Female; Humans; Hydroxychloroquine; Infant, | 1987 |